glp-1 next generation Retatrutide. The evolution. A next-generation triple agonist designed to advance metabolic research through GLP-1, GIP, and glucagon receptor pathways. Supporting innovation through trusted peptide sourcing. For healthcare professionals. Research Next-Generation Anti-Obesity Medicines | Pharmaceutical
Pay in 4 interest-free payments of $6.74 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11













00188-2/asset/060af149-96d8-44a2-9e4d-318ecc8ae69e/main.assets/gr1_lrg.jpg)











